FeRiva 21/7 by Avion Pharmaceuticals

🛒 Buy on Amazon

Supplement Facts

Serving Size: 1 Tablet(s), 1 time daily

Servings Per Container: 28

Amount Per Serving % Daily Value* (Adults and children 4 or more years of age)

Vitamin C (Ascorbic Acid) 175 mg 292%

Zinc (Zinc Bisglycinate) 10 mg 67%

Vitamin B12 (Cyanocobalamin) 12 mcg 200%

Iron (Ferrous Asparto Glycinate) 75 mg 417%

Folate 1,200 mcg DFE 430%

Vitamin B9 800 mcg

Folate 400 mcg

Succinic acid 150 mg †

* Not Present † Daily Value not established.

Other Ingredients: Croscarmellose Sodium, Dicalcium Phosphate, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid, FD&C Red #40, Hydroxypropylmethylcellulose, Titanium Dioxide, Triacetin, FD&C Red #3, FD&C Blue #1.

Statements

Suggested Use:

Once daily
28-day iron supplement regimen

Warnings:

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Precautions: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

While prescribing this nutritional supplement for pregnant women, nursing mothers or for women prior to conception, their medical condition and other drugs, herbs and/or supplements consumption should be considered.

Adverse reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Keep out of reach of children.

Storage:

Store between 20 degrees - 25 degrees C (68 degrees - 77 degrees F).

Other Information:

Unique, innovative iron supplementation system
Enhanced GI tolerability
Improved absorption
Easy-to-swallow tablets

Indications: FeRiva 21/7 is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.
Contraindictions: FeRiva 21/7 is contraindicated in patients with a known hypersensitivity to any of the ingredients. Hemochromatosis and hemosiderosis are contraindicated to iron therapy.

Sumalate is a registered trademark of Albion Laboratories, Inc., covered by one or more claims of U.S. Patent Nos. 6,716,814, 8,007,846, and 8,425,956.

FDA Disclaimer:

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Back to Search Results